7 multimodal genomic assays expanding cancer detection in 2026

a adăugat un sunet Health

2026-02-20 06:41:51 -

As 2026 unfolds, the shift toward multi-cancer early detection (MCED) via non-invasive testing is fundamentally altering the global oncology landscape. Regulatory agencies in the European Union and North America have recently streamlined the approval of multimodal genomic assays that analyze circulating tumor DNA (ctDNA) and methylation patterns simultaneously. This clinical progression is...

0 Commentarii 0 Distribuiri 202 Views 0 previzualizare